Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 12,000 | $38.07 | $456,840.00 |
DisclosureSEC source: 0001179110-13-017076 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,666,053 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 8,800 | $38.07 | $334,972.00 |
DisclosureSEC source: 0001179110-13-017076 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,678,053 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 2,800 | $38.06 | $106,568.00 |
DisclosureSEC source: 0001179110-13-017076 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,686,853 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 300,401 | $33.37 | $10,024,381.37 |
DisclosureSEC source: 0001179110-13-017076 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,689,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 600 | $38.36 | $23,016.00 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 16 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,389,252 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 1,000 | $38.35 | $38,350.00 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,389,852 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 2,800 | $38.34 | $107,352.00 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,390,852 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 100 | $38.31 | $3,831.00 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,393,652 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 300 | $38.31 | $11,491.50 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,393,752 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 300 | $38.30 | $11,490.00 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,394,052 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 3,183 | $38.29 | $121,877.07 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,394,352 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 9,888 | $38.27 | $378,413.76 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,397,535 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 4,100 | $38.27 | $156,886.50 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407,423 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 48,095 | $38.26 | $1,840,114.70 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,411,523 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 54,900 | $38.26 | $2,100,199.50 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,459,618 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 8,400 | $38.25 | $321,300.00 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,514,518 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 11,200 | $38.25 | $428,344.00 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,522,918 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 2,108 | $38.23 | $80,588.84 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,534,118 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 600 | $38.23 | $22,935.00 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,536,226 Read SEC document |
| November 22, 2013 Filed Nov 26, 2013 22:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 2,300 | $38.22 | $87,906.00 |
DisclosureSEC source: 0001179110-13-017078 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,536,826 Read SEC document |
| November 08, 2013 Filed Nov 8, 2013 22:08 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,227 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001179110-13-016351 · edgar.xml · derivative · entry 10 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,227 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 08, 2013 Filed Nov 8, 2013 22:08 UTC |
Fussell Stephen RExecutive Vice President
|
Tax withholdingCommon shares without par value | 642 | $37.64 | $24,164.88 |
DisclosureSEC source: 0001179110-13-016351 · edgar.xml · nonDerivative · entry 5 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,169 Read SEC document |
| November 08, 2013 Filed Nov 8, 2013 22:08 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionCommon shares without par value | 1,227 | $19.72 | $24,191.90 |
DisclosureSEC source: 0001179110-13-016351 · edgar.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2013 Filed Nov 8, 2013 22:08 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 7,558 | $0.00 Strike: $25.17 | $0.00 |
DisclosureSEC source: 0001179110-13-016351 · edgar.xml · derivative · entry 9 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 7,558 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 07, 2013 Filed Nov 8, 2013 22:08 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,908 | $0.00 Strike: $25.52 | $0.00 |
DisclosureSEC source: 0001179110-13-016351 · edgar.xml · derivative · entry 8 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,908 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 07, 2013 Filed Nov 8, 2013 22:08 UTC |
Fussell Stephen RExecutive Vice President
|
SaleCommon shares without par value | 10,466 | $37.59 | $393,416.94 |
DisclosureSEC source: 0001179110-13-016351 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,584 Read SEC document |
| November 07, 2013 Filed Nov 8, 2013 22:08 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionCommon shares without par value | 7,558 | $25.17 | $190,265.85 |
DisclosureSEC source: 0001179110-13-016351 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2013 Filed Nov 8, 2013 22:08 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,908 | $25.52 | $74,226.12 |
DisclosureSEC source: 0001179110-13-016351 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2013 Filed Mar 13, 2015 21:29 UTC |
Doyle Katherine C.Senior Vice President
|
PurchaseCommon shares without par value | 102 | $36.71 | $3,744.22 |
DisclosureSEC source: 0001179110-15-004891 · edgar.xml · nonDerivative · entry 1 Doyle Katherine C. · CIK 0001570003 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,429 F1 · shares: Purchase was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's sale of 200 shares of Abbott common shares at a price of $39.015 per share (including transaction costs), or $38.999 per share (excluding transaction costs), which was reported on March 4, 2014. The reporting person has paid to Abbott $239.70, representing the full amount of the profit realized in connection with these transactions, less transaction costs. Read SEC document |
| October 30, 2013 Filed Nov 1, 2013 21:04 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,715 | $0.00 Strike: $35.08 | $0.00 |
DisclosureSEC source: 0001179110-13-015959 · edgar.xml · derivative · entry 12 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 0 Underlying: Common shares · 2,715 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The reporting person disclaims beneficial ownership of all securities held by his spouse. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 30, 2013 Filed Nov 1, 2013 21:04 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,545 | $0.00 Strike: $35.08 | $0.00 |
DisclosureSEC source: 0001179110-13-015959 · edgar.xml · derivative · entry 11 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,545 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 30, 2013 Filed Nov 1, 2013 21:04 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 21,108 | $0.00 Strike: $33.37 | $0.00 |
DisclosureSEC source: 0001179110-13-015959 · edgar.xml · derivative · entry 10 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 21,108 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 30, 2013 Filed Nov 1, 2013 21:04 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 2,715 | $37.01 | $100,484.87 |
DisclosureSEC source: 0001179110-13-015959 · edgar.xml · nonDerivative · entry 7 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 2,066 F3 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his spouse. Read SEC document |
| October 30, 2013 Filed Nov 1, 2013 21:04 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,715 | $35.08 | $95,242.20 |
DisclosureSEC source: 0001179110-13-015959 · edgar.xml · nonDerivative · entry 6 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 4,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his spouse. Read SEC document |
| October 30, 2013 Filed Nov 1, 2013 21:04 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 22,653 | $36.83 | $834,230.70 |
DisclosureSEC source: 0001179110-13-015959 · edgar.xml · nonDerivative · entry 3 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,733 Read SEC document |
| October 30, 2013 Filed Nov 1, 2013 21:04 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,545 | $35.08 | $54,198.60 |
DisclosureSEC source: 0001179110-13-015959 · edgar.xml · nonDerivative · entry 2 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2013 Filed Nov 1, 2013 21:04 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionCommon shares without par value | 21,108 | $33.37 | $704,373.96 |
DisclosureSEC source: 0001179110-13-015959 · edgar.xml · nonDerivative · entry 1 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2013 Filed Oct 23, 2013 21:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 42,487 | $0.00 Strike: $34.93 | $0.00 |
DisclosureSEC source: 0001179110-13-015717 · edgar.xml · derivative · entry 10 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 42,487 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 21, 2013 Filed Oct 23, 2013 21:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 41,059 | $37.29 | $1,531,090.11 |
DisclosureSEC source: 0001179110-13-015717 · edgar.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,224 Read SEC document |
| October 21, 2013 Filed Oct 23, 2013 21:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 42,487 | $34.93 | $1,484,070.91 |
DisclosureSEC source: 0001179110-13-015717 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2013 Filed Oct 2, 2013 21:13 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 237 | $33.19 Strike: $0.00 | $7,866.03 |
DisclosureSEC source: 0001179110-13-014985 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,140 Underlying: Common shares · 237 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2013 Filed Oct 2, 2013 21:14 UTC |
OSBORN WILLIAM ADirector
|
GrantStock Equivalent Units · Derivative | 1,039 | $33.19 Strike: $0.00 | $34,484.41 |
DisclosureSEC source: 0001179110-13-014986 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,481 Underlying: Common shares · 1,039 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2013 Filed Oct 2, 2013 21:14 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 994 | $33.19 Strike: $0.00 | $32,990.86 |
DisclosureSEC source: 0001179110-13-014987 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,503 Underlying: Common shares · 994 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2013 Filed Oct 2, 2013 21:14 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 994 | $33.19 Strike: $0.00 | $32,990.86 |
DisclosureSEC source: 0001179110-13-014988 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,832 Underlying: Common shares · 994 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 17, 2013 Filed Sep 19, 2013 22:37 UTC |
Forrest A. DavidSenior Vice President
|
Tax withholdingCommon shares without par value | 10,732 | $35.01 | $375,727.32 |
DisclosureSEC source: 0001179110-13-014419 · edgar.xml · nonDerivative · entry 2 Forrest A. David · CIK 0001501589 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,013 Read SEC document |
| September 17, 2013 Filed Sep 19, 2013 22:37 UTC |
Forrest A. DavidSenior Vice President
|
GrantCommon shares without par value | 22,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-014419 · edgar.xml · nonDerivative · entry 1 Forrest A. David · CIK 0001501589 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,745 F1 · shares: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 22, 2013 Filed Jul 24, 2013 21:33 UTC |
ALLEN HUBERT LExecutive Vice President
|
SaleCommon shares without par value | 146 | $35.75 | $5,219.50 |
DisclosureSEC source: 0001179110-13-012075 · edgar.xml · nonDerivative · entry 1 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,107 Read SEC document |
| July 01, 2013 Filed Jul 3, 2013 21:46 UTC |
DeVos Georges H.Senior Vice President
|
GrantOption (right to buy) · Derivative | 119,700 | $0.00 Strike: $35.20 | $0.00 |
DisclosureSEC source: 0001179110-13-011552 · edgar.xml · derivative · entry 1 DeVos Georges H. · CIK 0001580246 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,700 Underlying: Common shares · 119,700 shares Expires 2023-06-30 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 39,900 on 7/1/2014, 39,900 on 7/1/2015, and 39,900 on 7/1/2016. Read SEC document |
| July 01, 2013 Filed Jul 3, 2013 21:46 UTC |
Pavee Jean-YvesSenior Vice President
|
GrantOption (right to buy) · Derivative | 119,700 | $0.00 Strike: $35.20 | $0.00 |
DisclosureSEC source: 0001179110-13-011553 · edgar.xml · derivative · entry 1 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,700 Underlying: Common shares · 119,700 shares Expires 2023-06-30 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 39,900 on 7/1/2014, 39,900 on 7/1/2015, and 39,900 on 7/1/2016. Read SEC document |
| June 30, 2013 Filed Jul 2, 2013 21:56 UTC |
ALLEN HUBERT LExecutive Vice President
|
Tax withholdingCommon shares without par value | 324 | $34.88 | $11,301.12 |
DisclosureSEC source: 0001179110-13-011335 · edgar.xml · nonDerivative · entry 1 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,253 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.